Autologous Stem Cell Transplantation versus Alemtuzumab, Ocrelizumab, Ofatumumab or Cladribine in Relapsing Remitting Multiple Sclerosis

Click on the video below to find out about us!

Star-MS trial anoucement.mp4


Click here, or on the link below to watch a clip from BBC Look North (Yorkshire) titled MS stem cell trial could revolutionise care for patients with 'aggressive' MS, shown on Tuesday 29th October 2022. We would like to thank BBC Look North for allowing the StarMS website to share this article.

This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership. The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NIHR or the Department of Health and Social Care. The sponsor is the Sheffield Teaching Hospitals NHS Foundation Trust.